All Type of News
GSK undecided on price of Cervarix vaccine
GlaxoSmithKline has yet to decide on price, launching date and partnership of Cervarix, cervical cancer vaccine, a GSK official said on September 1.
The company is scheduled for Cervarix’s launching symposium soon ...
KPMA calls for scrapping of economic effectiveness evaluation system over medicines
The Korea Pharmaceutical Manufacturers Association (KPMA) has urged the government not to evaluate the economic effectiveness of conventional medicines to reduce their prices on a regular basis.
In a statement deli...
Kwangdong’s U to emerge as lead market
Kwangdong Pharm’s Uwhangchungsimwon (UC) is likely to regain its momentum as the market’s leading player Chosun Pharm is unable to release its products due to in-house problems, according to pharmaceutical business so...
KPIC opens drug related Web siteThe Korea Pharmaceutical Information Center says it has opened a Web site (health.kr) to provide its full screening services for 40,000 medicines which are on the market.
A K...
|
Dongsung to distribute Genex’s Oral-LynDongsung Pharm says it has entered into an exclusive licensing and distribution agreement with the U.S. Generex biotechnology corporation for the importation, marketing, distrib...
|
Drug makers cancel licenses of 43,109 medicines voluntarily for 5 years
Pharmaceutical companies have voluntarily cancelled a total of 43,109 drugs since 2003, according to the Korea Food and Drug Administration.
These voluntarily-cancelled items are chiefly related to little marketabi...
Court upholds SNUH’s redemption of 4.1 billion won in medication costs
A Seoul court has ruled that the Seoul National University Hospital’s redemption request of 4.1 billion won in medication costs was justified because SNUH doctors prescribed necessary drugs based on their medical rati...
Wyeth Korea reshuffles top deck
Wyeth Korea announced on September 1 that it has reshuffled eight top-level executives of its new business units.
The company said that the changes, which take effect starting September 1, have been made to reflec...
Ex-AZ China vice president named new AZ Korea presidentTom Keith-Roach, a former vice president of AstraZeneca China, has been appointed the new head of AstraZeneca Korea as of September 1.
“I'll make efforts to improve recogniti...
|
Bayer Schering appoints new chief for Philippines branchBayer Schering Pharma announced on September 1 that Noh Sang-kyung, ex-vice president for strategy and development in Asia-Pacific region, was appointed as its new president for...
|
